Probucol in long-term treatment of hypercholesterolemia
- 1 January 1988
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 19 (3) , 317-320
- https://doi.org/10.1016/0306-3623(88)90023-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cholesterol and Coronary Heart DiseaseJAMA, 1986
- Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery diseaseThe American Journal of Cardiology, 1986
- Controlled studies of the efficacy and safety of combined probucol-colestipol therapyThe American Journal of Cardiology, 1986
- Medical management of hyperlipidemia and the role of probucolThe American Journal of Cardiology, 1986
- Lipoprotein fractions and receptors: A role for probucol?The American Journal of Cardiology, 1986
- Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemiaAtherosclerosis, 1985
- The hypolipidemic action of probucolAtherosclerosis, 1985
- On the Mechanism of Plasma Cholesterol Reduction in the Rat Given ProbucolClinical Science, 1981
- QT-Interval Prolongation Produced by ProbucolArchives of internal medicine (1960), 1981
- Long‐Term Oral Administration of Probucol [4, 4‘‐(Isopropylidenedithio) bis (2, 6‐di‐t‐Butylphenol)] (DH‐581) in the Management of Hypercholesterolemia*Journal of the American Geriatrics Society, 1974